Check here to see clinical cancer trials that are currently enrolling patients.

Below you will see clinical cancer trials in Eastern Finland.

Cancer trials

ONCOLOGY

TALAPRO-2, prostate cancer

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

DART, lung cancer

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

BIO-CHIC, lymphoma

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

POLARBEAR, lymphoma

This is a phase III, randomized, open-label, multicenter trial, conducted in Sweden, Norway, Finland, Denmark, Italy and Switzerland, in elderly patients with untreated diffuse large B-cell lymphoma.

 

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

MK6482-005, kidney cancer

 

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

CA045-001, melanoma

 

RECRUITING STARTS ON AUTUMN 2020

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

IPATUNITY 170, breast cancer

Randomized Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer.

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

KuPSMALu-177, prostate cancer

RECRUITING STARTS ON AUTUMN 2020

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

LCBIOMARKERS, lung cancer

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

IOPredict

 

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.

 

COVID and Cancer

Research about how COVID affects to cancer patients.

RECRUITING

To get more information contact:

Okko Kääriäinen
okko.kaariainen@kuh.fi
044-7179433

Updated 25 August 2020.